• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌不再仅仅是一种医院感染或成人感染。

Clostridium difficile is no longer just a nosocomial infection or an infection of adults.

作者信息

Pituch Hanna

机构信息

Department of Medical Microbiology, The Medical University of Warsaw, 5 Chalubinski Street, Warsaw, Poland.

出版信息

Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S42-5. doi: 10.1016/S0924-8579(09)70016-0.

DOI:10.1016/S0924-8579(09)70016-0
PMID:19303569
Abstract

Clostridium difficile is the main cause of nosocomial gastrointestinal disorders. Historically, C. difficile has usually affected older patients, hospital inpatients, and long-term care facility residents. Recent reports suggest that the occurrence and severity of C. difficile-associated disease (CDAD) is increasing in populations previously considered to be at low risk of the infection, and increasing numbers of community-acquired cases of CDAD are being reported. Risk factors for CDAD in paediatric patients include disruption of the normal microflora of the gastrointestinal tract (antibiotic-associated and non-antibiotic-associated), age, immune status, diet, underlying conditions, concurrent infections, and cancer. CDAD in populations previously thought to be at low risk is an emerging problem.

摘要

艰难梭菌是医院获得性胃肠道疾病的主要病因。从历史上看,艰难梭菌通常影响老年患者、住院患者和长期护理机构居民。最近的报告表明,在以前被认为感染风险较低的人群中,艰难梭菌相关疾病(CDAD)的发生率和严重程度正在增加,并且社区获得性CDAD病例的报告数量也在增加。儿科患者发生CDAD的风险因素包括胃肠道正常微生物群的破坏(与抗生素相关和与非抗生素相关)、年龄、免疫状态、饮食、基础疾病、并发感染和癌症。以前被认为风险较低的人群中出现CDAD是一个新出现的问题。

相似文献

1
Clostridium difficile is no longer just a nosocomial infection or an infection of adults.艰难梭菌不再仅仅是一种医院感染或成人感染。
Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S42-5. doi: 10.1016/S0924-8579(09)70016-0.
2
Surveillance for community-associated Clostridium difficile--Connecticut, 2006.2006年康涅狄格州社区相关性艰难梭菌监测
MMWR Morb Mortal Wkly Rep. 2008 Apr 4;57(13):340-3.
3
Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.2005年,四个州此前低风险人群中出现的严重艰难梭菌相关疾病
MMWR Morb Mortal Wkly Rep. 2005 Dec 2;54(47):1201-5.
4
The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.艰难梭菌感染在住院和门诊环境中的发病率和严重程度不断增加。
Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):409-16. doi: 10.1586/egh.10.48.
5
Established and potential risk factors for Clostridum difficile infection.艰难梭菌感染的既定风险因素和潜在风险因素。
Indian J Med Microbiol. 2009 Oct-Dec;27(4):289-300. doi: 10.4103/0255-0857.55436.
6
Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.社区获得性艰难梭菌相关性腹泻,与抗生素使用无关——两例病例报告并回顾艰难梭菌相关性腹泻不断变化的流行病学情况
Neth J Med. 2008 May;66(5):207-11.
7
Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005.2005年荷兰艰难梭菌相关疾病的特征与发病率
Clin Microbiol Infect. 2007 Nov;13(11):1058-64. doi: 10.1111/j.1469-0691.2007.01793.x.
8
New views on Clostridium difficile infections: Introduction.艰难梭菌感染的新观点:引言
Int J Antimicrob Agents. 2009 Mar;33 Suppl 1:S1. doi: 10.1016/S0924-8579(09)70007-X.
9
[Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].[艰难梭菌腹泻:在阿根廷布宜诺斯艾利斯一家医疗中心的检出频率]
Rev Argent Microbiol. 2001 Apr-Jun;33(2):101-7.
10
[Clostridium difficile and diarrhea associated with the use of antibiotics in the origin of nosocomial and community-acquired diarrhea].[艰难梭菌与医院获得性和社区获得性腹泻病因中抗生素使用相关的腹泻]
Enferm Infecc Microbiol Clin. 1996 Feb;14(2):96-100.

引用本文的文献

1
Global burden and trends of the infection-associated diseases from 1990 to 2021: an observational trend study.1990年至2021年感染相关疾病的全球负担及趋势:一项观察性趋势研究
Ann Med. 2025 Dec;57(1):2451762. doi: 10.1080/07853890.2025.2451762. Epub 2025 Jan 23.
2
Enigmatic Pilus-Like Endospore Appendages of Group Species.具有神秘性的类群种芽孢杆菌样内生孢子附属物。
Int J Mol Sci. 2021 Nov 16;22(22):12367. doi: 10.3390/ijms222212367.
3
Modeling Clostridium difficile in a hospital setting: control and admissions of colonized and symptomatic patients.
医院环境中艰难梭菌的建模:定植和有症状患者的控制与入院情况
Theor Biol Med Model. 2019 Jan 31;16(1):2. doi: 10.1186/s12976-019-0098-0.
4
Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis.发展中国家艰难梭菌相关性腹泻:一项系统评价与荟萃分析
Infect Dis Ther. 2019 Mar;8(1):87-103. doi: 10.1007/s40121-019-0231-8. Epub 2019 Jan 18.
5
uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.使用与部分腹泻患者肠道微生物失调相关的氨基酸。
Sci Transl Med. 2018 Oct 24;10(464). doi: 10.1126/scitranslmed.aam7019.
6
Risk factors for poor outcome in community-onset infection.社区获得性感染不良预后的危险因素。
Antimicrob Resist Infect Control. 2018 Jun 15;7:75. doi: 10.1186/s13756-018-0365-6. eCollection 2018.
7
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection.一种基于四特异性VHH的中和抗体改变艰难梭菌感染三种动物模型的疾病结局。
Clin Vaccine Immunol. 2016 Sep 6;23(9):774-84. doi: 10.1128/CVI.00730-15. Print 2016 Sep.
8
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.社区相关性艰难梭菌感染的流行病学和危险因素:一篇叙述性综述。
Infect Dis Ther. 2016 Sep;5(3):231-51. doi: 10.1007/s40121-016-0117-y. Epub 2016 Jul 1.
9
Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.艰难梭菌感染中抗生素耐药性认识的最新进展
Ther Adv Infect Dis. 2016 Feb;3(1):23-42. doi: 10.1177/2049936115622891.
10
Human microbiome: From the bathroom to the bedside.人类微生物组:从浴室到床边。
World J Gastrointest Pathophysiol. 2015 Aug 15;6(3):79-85. doi: 10.4291/wjgp.v6.i3.79.